Skip to Content
You are currently on the new version of our website. Access the old version .
  • Article
  • Open Access

17 May 2020

17 Pages

Advancing the Science and Management of Renal Cell Carcinoma: Bridging the Divide between Academic and Community Practices

,
,
,
and
1
Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA 91107, USA
2
University of California San Francisco School of Medicine, San Francisco, CA 94143, USA
3
Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Corona, CA 92879, USA
4
Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, South Pasadena, CA 91030, USA

Abstract

The treatment of metastatic renal cell carcinoma (mRCC) has rapidly evolved; however, the progress made in the field is heavily contingent upon timely and efficient accrual to clinical trials. While a substantial proportion of accrual occurs at tertiary care centers, community sites are playing an increasing role in patient recruitment. In this article, we discuss strategies to optimize collaborations between academic and community sites to facilitate clinical research. Further, as the role of biomarker discovery has become increasingly important in tailoring therapy, we will discuss opportunities to bridge diverse accrual sites for the purpose of translational research.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.